Lichen Funds

Lichen Funds

Founded in 2014 and headquartered in Shanghai, Lichen Funds operates as a private equity fund-of-funds manager focused exclusively on China. The firm constructs portfolios by committing to domestic buyout, growth equity, and venture capital funds, spanning seed, early-stage, and expansion strategies. Its founding team brought experience in institutional asset allocation at a time when China's PE market was maturing rapidly and domestic limited partners were scarce relative to the number of emerging managers. Lichen positioned itself as an aggregator, pooling capital from Chinese institutions and family offices to access GP relationships that foreign LPs often cannot reach directly. Lichen's strategy covers the full lifecycle of Chinese private markets — from seed and startup venture through expansion and late-stage growth to control buyouts. The firm is sector-agnostic by design, allocating across consumer, healthcare, technology, and advanced manufacturing as opportunities shift, rather than betting on thematic concentration. Fund commitments form the core of deployment, supplemented by occasional direct co-investments alongside trusted GPs. The geographic scope remains domestic China, where regulatory fragmentation creates a persistent need for local LP expertise in fund selection, due diligence, and ongoing monitoring. This domestic focus insulates the firm from cross-border capital-control risks that complicate outbound strategies. Lichen Funds does not publicly disclose assets under management or team headcount, reflecting the broader opacity of China's private-equity fund-of-funds segment. Its structure as a pure-play fund-of-funds manager, without captive direct-investment teams or affiliated GPs, is unusual in China's market, where many LP platforms eventually internalize investment capabilities. Recent regulatory reforms requiring greater disclosure from private fund managers have reinforced the value of compliance-oriented intermediaries, likely strengthening Lichen's role as a gatekeeper for allocators seeking China exposure without building onshore infrastructure. Lichen's structural differentiator is its pure intermediary posture: it operates as an independent fund-of-funds without direct-investment conflicts, co-mingled proprietary capital, or GP affiliations. This alignment with LP interests stands in contrast to many Chinese platforms that blur the line between fund selection and direct deployment. As China's private fund industry consolidates under tighter regulation, Lichen's model offers a governance premium — a third-party LP function in a market where GPs and LPs often share overlapping interests. The firm's durability depends on maintaining this independence while the surrounding ecosystem pushes toward vertical integration.